Main Page
About US
Director Message
No. Decision and Establashment Date
vision & mission
Our objectives
Our achievements
Organization Chart
Administration
Executive Board
Administrative Board
Scientific Advisor Committee
Postgraduate Committee
Ethical Committee
Elite Student Program Committee
Administrative Unit
Secretary Unit
Employment Unit
Ordering and Purchasing Unit
IT Unit
Financial Unit
Public Relations and Marketing Unit
Transportation Unit
Researchers
Senior Staff
Research Leaders
Research Staff
Technical Staff Labs
Research Programs
About Research Programs
Biobanking & Biospecimen Research Program
Cancer Genomic Research Program
Functional & Developmental Genomics Research Progr
Genomic Screening Research Program
Neurogenetic Research Program
Pharmacogenomics Research Program
Tissue Culture & Regenerative Medicine Research
Research Service Units
About Research Service Units
Biobanking Unit
Bioimaging Unit
Bioinformatics Unit
Biomedical Engineering Unit
Diagnostic & Genomic Medicine Unit (DGMU)
Cytogenetic Service Unit
Molecular Service Unit
Flowcytometry Unit
Genetic Counselling Unit
High-Throughput Sequencing Unit
Histopathology Unit
Microarray (Affymetrix) Unit
Microarray (Agilent) Unit
Pharmacogenomics & Drug Discovery Unit
Preimplantation Genetic Diagnosis Unit
Proteomics and Metabolomics Unit
Quantitative Genotyping Unit
Teratogenecity & Toxicity Unit
Tissue Culture Unit
Education & Outreach Program
About Education & Outreach Program
Master of Science Program
About the Program
Master Students
Doctor of Philosophy Program
About the Program
Ph.D. Students
Training Program
About Program
Specialized Training Program in Clinical Cyto.
Public Awareness Program
Collaborations
About Collaborations
National Level Collaborations
International Level Collaborations
Quality Management Program
About Quality Management Program
QMP Outline
QMP Aims and Function
Publications
CEGMR Publication List
Submit Publication Permission Request
CEGMR Booklets
CEGMR Newsletter
CEGMR Workshops
Conferences and Seminars
CEGMR Training Programs
Conferences & Workshops
Conferences
Workshops
Seminars and Training Courses
Parteners
Academic Parteners
National
International
Commercial Parteners
National
International
Related Links
Government
Journals
Non-Governmental Organizations
International Organizations
Medical Dictionaries
Search Engines for Researchers
PhotoAlbum
Files
Contact Us
Center map
Site Map
Latest News
Our Events
CEGMR Research
Research
Application for Employment
عربي
English
About
Admission
Academic
Research and Innovations
University Life
E-Services
Search
Center of Excellence In Genomic Medicine Research
Document Details
Document Type
:
Article In Journal
Document Title
:
Tumour specific promoter region methylation of the human homologue of the Drosophila Roundabout gene DUTT1 (ROBO1) in human cancers
Tumour specific promoter region methylation of the human homologue of the Drosophila Roundabout gene DUTT1 (ROBO1) in human cancers
Document Language
:
English
Abstract
:
The human homologue of the Drosophila Roundabout gene DUTT1 (Deleted in U Twenty Twenty) or ROBO1 (Locus Link ID 6091), a member of the NCAM family of receptors, was recently cloned from the lung cancer tumour suppressor gene region 2 (LCTSGR2 or U2020 region) at 3p12. DUTT1 maps within a region of overlapping homozygous deletions characterized in both small cell lung cancer lines (SCLC) and in a breast cancer line. In this report we (a) de®ned the genomic organization of the DUTT1 gene, (b) performed mutation and expression analysis of DUTT1 in lung, breast and kidney cancers, (c) identi®ed tumour speci®c promoter region methylation of DUTT1 in human cancers. The gene was found to contain 29 exons and spans at least 240 kb of genomic sequence. The 5' region contains a CpG island, and the poly(A)+ tail has an atypical 5'-GATAAA-3' signal. We analysed DUTT1 for mutations in lung, breast and kidney cancers, no inactivating mutations were detected by PCR± SSCP. However, seven germline missense changes were found and characterized. DUTT1 expression was not detectable in one out of 18 breast tumour lines analysed by RT± PCR. Bisul®te sequencing of the promoter region of DUTT1 gene in the HTB-19 breast tumour cell line (not expressing DUTT1) showed complete hypermethylation of CpG sites within the promoter region of the DUTT1 gene (7244 to +27 relative to the translation start site). The expression of DUTT1 gene was reactivated in HTB- 19 after treatment with the demethylating agent 5-aza-2'- deoxycytidine. The same region was also found to be hypermethylated in six out of 32 (19%) primary invasive breast carcinomas and eight out of 44 (18%) primary clear cell renal cell carcinomas (CC ±RCC) and in one out of 26 (4%) primary NSCLC tumours. Furthermore 80% of breast and 75% of CC±RCC tumours showing DUTT1 methylation had allelic losses for 3p12 markers hence obeying Knudson's two hit hypothesis. Our ®ndings suggest that DUTT1 warrants further analysis as a candidate for the tumour suppressor gene (TSG) at 3p12, a region de®ned by hemi and homozygous deletions and functional analysis.
ISSN
:
1476-5594
Journal Name
:
Oncogene
Volume
:
22
Issue Number
:
19
Publishing Year
:
1423 AH
2002 AD
Article Type
:
Article
Added Date
:
Monday, April 26, 2010
Researchers
Researcher Name (Arabic)
Researcher Name (English)
Researcher Type
Dr Grade
Email
فريدة لطيف
latif, Farida
Investigator
Doctorate
flatif@hgmp.mrc.ac.uk
أشرف دلول
Dallol, Ashraf
Researcher
Doctorate
Back To Researches Page